Billiontoone (NASDAQ:BLLN) Sees Unusually-High Trading Volume – Still a Buy?

Billiontoone, Inc. (NASDAQ:BLLN) shares saw unusually-strong trading volume on Tuesday . Approximately 938,737 shares changed hands during trading, an increase of 194% from the previous session’s volume of 318,964 shares.The stock last traded at $76.9530 and had previously closed at $72.12.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on BLLN shares. Guggenheim reduced their price target on shares of Billiontoone from $120.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, March 30th. BTIG Research reduced their price target on shares of Billiontoone from $160.00 to $140.00 and set a “buy” rating for the company in a research report on Thursday, March 5th. Weiss Ratings restated a “sell (d)” rating on shares of Billiontoone in a research report on Friday. Wells Fargo & Company cut their price objective on Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a research report on Thursday, March 5th. Finally, Wall Street Zen upgraded Billiontoone from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. Six analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Billiontoone presently has a consensus rating of “Moderate Buy” and an average price target of $126.71.

Billiontoone Trading Up 7.9%

The stock has a market capitalization of $3.58 billion and a PE ratio of 370.80. The company has a debt-to-equity ratio of 0.12, a current ratio of 11.69 and a quick ratio of 11.32. The stock has a 50 day moving average of $77.44.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings data on Wednesday, March 4th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.07. The company had revenue of $96.05 million for the quarter, compared to analysts’ expectations of $85.85 million. Billiontoone’s revenue was up 113.0% on a year-over-year basis. As a group, analysts predict that Billiontoone, Inc. will post 0.42 EPS for the current year.

Hedge Funds Weigh In On Billiontoone

Institutional investors have recently added to or reduced their stakes in the company. Rossby Financial LCC acquired a new position in Billiontoone in the 4th quarter worth $25,000. Wells Fargo & Company MN acquired a new position in Billiontoone in the 4th quarter worth $76,000. Smartleaf Asset Management LLC acquired a new position in Billiontoone in the 4th quarter worth $80,000. Nano Cap New Millennium Growth Fund L P acquired a new position in Billiontoone in the 4th quarter worth $82,000. Finally, Renaissance Capital LLC acquired a new position in Billiontoone in the 4th quarter worth $201,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.